Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026 ...Middle East

GUANGZHOU, China, Oct. 24, 2026 /PRNewswire/ -- Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced the presentation of clinical data for BAT8008, a TROP2-targeted antibody-drug conjugate...

Hence then, the article about bio thera announces promising clinical data for bat8008 in combination with bat1308 in first line non small cell lung cancer at esmo 2026 was published today ( Saturday 24/10/2026 - 02:01 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026 )

Also on site :

• iPhone Duo Launches in Santa Barbara
• Starbucks China tells customers to buy something before they sit down, as it invests $45 million in the store experience
• 1999 Cult-Favorite TV Series Featured Van Halen, Rush, Styx—And Has the ‘Greatest Halloween Episode of All Time’